Cyclohexanesulfonyl chloride

CAS : 4837-38-1

Ref. 3D-FC53297

Informations sur le produit

• Nom: Cyclohexanesulfonyl chloride
• Synonymes: Cyclohexylsulfonyl chloride

Description

Cyclohexanesulfonyl chloride (CHSC) is an enzyme inhibitor that prevents the formation of fatty acid by inhibiting the enzyme delta-9-desaturase. CHSC has been shown to react with chloride ions in the liver and cause hepatitis, a condition characterized by inflammation of the liver. CHSC has been used as a radiation sensitizer in cancer therapy and is also used for treatment of metabolic disorders such as obesity and diabetes. Cyclohexanesulfonyl chloride binds to cannabinoid receptors, cb1 and cb2, with high affinity and can activate them. The activation of these receptors leads to hyperproliferative diseases such as cancer. CHSC reacts with hydrochloric acid to produce hydrogen sulfide gas, which causes high affinity binding at cb1 receptor sites.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 182.67 g/mol
• Formule: C₆H₁₁ClO₂S
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C6H11ClO2S/c7-10(8,9)6-4-2-1-3-5-6/h6H,1-5H2
• Code InChI: InChIKey=MJWVCJUSRGLHFO-UHFFFAOYSA-N
• SMILES: O=S(=O)(Cl)C1CCCCC1